Biology subjects

Bellmann-Strobl, J.

Publications and source records attributed to Bellmann-Strobl, J..

3 recordsLinked to original sources

bioRxiv2022

Comparable neural pathways link psychological stress and brain health in health and multiple sclerosis

Clinical and neuroscientific studies suggest a link between psychological stress and reduced brain health - in healthy humans and patients with neurological disorders. However, it is unclear which neural pathways mediate between stress and brain health and whether these pathways are similar in health and disease. Here, we applied an Arterial-Spin-Labeling MRI stress task in 42 healthy persons and 56 with multiple sclerosis. We tested whether brain-predicted age differences ("brain-PAD"), a highly sensitive structural brain health biomarker derived from machine learning, mirror functional connectivity between stress-responsive regions. We found that regional neural stress responsivity did not differ between groups. Although elevated brain-PAD indicated worse brain health in patients, anterior insula-occipital functional connectivity correlated with brain-PAD in both groups. Grey matter variations contributed similarly to brain-PAD in both groups. These findings suggest a generic connection between stress and brain health whose impact is amplified in multiple sclerosis by disease-specific vulnerability factors.

neuroscience↗

bioRxiv2022

Functional connectivity dynamics reflect disability and multi-domain clinical impairment in patients with relapsing-remitting multiple sclerosis

BackgroundFunctional neuroimaging studies have revealed complex and heterogeneous patterns of aberrant functional connectivity (FC) in multiple sclerosis (MS), yet it remains unclear how time-resolved FC relates to variance in clinical disease severity. ObjectivesTo characterize brain activity in MS patients with time-resolved FC analysis and explore the relationship between disease severity, multi-domain impairments, and altered network dynamics. MethodsResting-state functional MRI data were acquired from 101 MS patients and 101 age- and sex-matched healthy controls (HC). Dynamic FC analysis identified five connectivity states that were compared between HC and patients with high vs. low disability. ResultsPatients with higher disease severity exhibited a more widespread spatiotemporal pattern of altered FC and spent more time in a high-connectivity, low-occurrence state compared to patients with lower disease severity and HC. Depressive symptom severity was positively related to functional dynamics on global and network scales in patients, while fatigue and motor impairment were inversely related to frontoparietal network connectivity with the basal ganglia. ConclusionsTime-resolved FC analysis uncovered alterations in network dynamics and clinical correlations that remained undetected with a static account of brain activity. Such time-varying approaches are thus crucial for disentangling the relationship between brain dynamics, disease severity, and symptoms in MS.

neuroscience↗

bioRxiv2019

Low-Density Granulocytes are a novel immunopathological feature in both Multiple Sclerosis and Neuromyelitis optica spectrum disorder.

ObjectiveTo investigate whether low-density granulocytes (LDGs) are a immunophenotypic feature of patients with multiple sclerosis (MS) and/or neuromyelitis optica spectrum disorder (NMOSD).\n\nMethodsBlood samples were collected from 26 patients with NMOSD and 20 patients with MS, as well as from 18 patients with Systemic Lupus Erythematosus (SLE) and 23 Healthy Donors (HD). We isolated peripheral blood mononuclear cells (PBMCs) with density gradient separation and stained the cells with antibodies against CD14, CD15, CD16, and CD45, and analysed the cells by flow cytometry or imaging flow cytometry. We defined LDGs as CD14-CD15high and calculated their share in total PBMC leukocytes (CD45+) as well as the share of CD16hi LDGs. Clinical data on disease course, medication, and antibody status were obtained.\n\nResultsLDGs were significantly more common in MS and NMOSD than in HDs, comparable to SLE samples (median values HD 0.2%, MS 0.9%, NMOSD 2.1%, SLE 4.3%). 0/23 of the HDs, but 17/20 NMOSD and 11/17 MS samples as well as 13/15 SLE samples had at least 0.7 % LDGs. NMOSD patients without continuous immunosuppressive treatment had significantly more LDGs compared to their treated counterparts. LDG nuclear morphology ranged from segmented to rounded, suggesting a heterogeneity within the group.\n\nConclusionLDGs are a feature of the immunophenotype in some patients with MS and NMOSD.

immunology↗